Our Team
Dr. Mark Dubé, MD, CCFP(EM,PC,AM), FCFP, CISAM President and Founder
Mark Dubé, MD, President and Founder of UPTru ,has 25 years experience in addiction medicine, and is triple certified in Addiction, Emergency, and Palliative Care Medicine. He is a member of the American Society of Addiction Medicine and a certificant of the International Society of Addiction Medicine. He is Associate Professor, Clinical Science, Northern Ontario School of Medicine, Canada. Mark has spoken at the annual Family Medicine Forum on the topic of the Opioid Crisis for the last six years.
Dr. Ian Dubé, Ph.D, M.B.A.
Chief Scientific Officer (CSO)
Ian Dubé, Ph.D, M.B.A., CSO of UPTru, has three decades of experience in clinical and administrative Laboratory Medicine and management consulting. Past positions include Professor and Head, Department of Laboratory Medicine, Sunnybrook Hospital, University of Toronto and Lead Clinical Advisor, Laboratories Branch, British Columbia Ministry of Health, Canada. Ian has over 100 peer-reviewed articles in top ranked medical/scientific journals.
Together, Mark Dubé and Ian Dubé bring UPTru 75+ years of excellence in addiction medicine, clinical laboratory testing, academic medicine, clinical research, and business management. Their combined expertise is now directed at bringing UPTru’s innovative solution to urine drug test specimen alteration to routine clinical practice.